0001544227-21-000013.txt : 20210319
0001544227-21-000013.hdr.sgml : 20210319
20210319164756
ACCESSION NUMBER: 0001544227-21-000013
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210317
FILED AS OF DATE: 20210319
DATE AS OF CHANGE: 20210319
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Owens Julia C.
CENTRAL INDEX KEY: 0001760219
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35890
FILM NUMBER: 21758810
MAIL ADDRESS:
STREET 1: C/O OVASCIENCE, INC.
STREET 2: 9 FOURTH AVENUE
CITY: WALTHAM
STATE: MA
ZIP: 02451
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Millendo Therapeutics, Inc.
CENTRAL INDEX KEY: 0001544227
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 451472564
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 110 MILLER AVENUE, SUITE 100
CITY: ANN ARBOR
STATE: MI
ZIP: 48104
BUSINESS PHONE: 734-845-9000
MAIL ADDRESS:
STREET 1: 110 MILLER AVENUE, SUITE 100
CITY: ANN ARBOR
STATE: MI
ZIP: 48104
FORMER COMPANY:
FORMER CONFORMED NAME: OvaScience, Inc.
DATE OF NAME CHANGE: 20120308
4
1
wf-form4_161618685991338.xml
FORM 4
X0306
4
2021-03-17
0
0001544227
Millendo Therapeutics, Inc.
MLND
0001760219
Owens Julia C.
C/O MILLENDO THERAPEUTICS, INC.
110 MILLER AVENUE, SUITE 100
ANN ARBOR
MI
48104
1
1
0
0
Executive Chair
Stock Option (right to buy)
2.29
2021-03-17
4
A
0
24000
0
A
2031-03-16
Common Stock
24000.0
24000
D
One-third (1/3) of the shares subject to this option shall vest on February 1, 2022, and one twenty-fourth (1/24th) of the remaining shares subject to this option shall vest each month thereafter, subject to the Reporting Person continuing to provide service through each such date. However, all such options, to the extent outstanding immediately prior to a Change in Control (as defined in the 2019 Equity Incentive Plan), will be (or will be deemed to have been) fully vested and exercisable as of immediately prior to such Change in Control.
/s/ Jason Minio, Attorney-in-Fact
2021-03-19